$AMGN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMGEN INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AMGEN INC. Get notifications about new insider transactions in AMGEN INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 19 2021 | AMGN | AMGEN INC | MILES AMY E | Director | Grant | A | 0.00 | 837 | 0 | 1,245 | 408 to 1.2 K (+205.15 %) |
May 19 2021 | AMGN | AMGEN INC | Kullman Ellen Jamison | Director | Grant | A | 0.00 | 837 | 0 | 7,931 | 7.1 K to 7.9 K (+11.80 %) |
May 19 2021 | AMGN | AMGEN INC | Jacks Tyler | Director | Grant | A | 0.00 | 837 | 0 | 12,410 | 11.6 K to 12.4 K (+7.23 %) |
May 19 2021 | AMGN | AMGEN INC | HOLLEY CHARLES M | Director | Grant | A | 0.00 | 837 | 0 | 5,093 | 4.3 K to 5.1 K (+19.67 %) |
May 12 2021 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Option Exercise | M | 71.64 | 1,000 | 71,640 | 0 | |
May 12 2021 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Sell | S | 250.59 | 1,000 | 250,590 | 15,927 | 16.9 K to 15.9 K (-5.91 %) |
May 12 2021 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Buy | M | 71.64 | 1,000 | 71,640 | 16,927 | 15.9 K to 16.9 K (+6.28 %) |
May 12 2021 | AMGN | AMGEN INC | Grygiel Nancy A. | SVP & CCO | Option Exercise | M | 162.60 | 2,500 | 406,500 | 1,639 | |
May 12 2021 | AMGN | AMGEN INC | Grygiel Nancy A. | SVP & CCO | Sell | S | 252.51 | 2,500 | 631,272 | 12,461 | 15 K to 12.5 K (-16.71 %) |
May 12 2021 | AMGN | AMGEN INC | Grygiel Nancy A. | SVP & CCO | Buy | M | 162.60 | 2,500 | 406,500 | 14,961 | 12.5 K to 15 K (+20.06 %) |
May 10 2021 | AMGN | AMGEN INC | Williams R Sanders | Director | Sell | S | 251.78 | 250 | 62,945 | 4,409 | 4.7 K to 4.4 K (-5.37 %) |
May 04 2021 | AMGN | AMGEN INC | Santos Esteban | EVP, Operations | Option Exercise | A | 239.64 | 34,420 | 8,248,409 | 34,420 | |
May 04 2021 | AMGN | AMGEN INC | Santos Esteban | EVP, Operations | Payment of Exercise | F | 239.64 | 685 | 164,153 | 51,108 | 51.8 K to 51.1 K (-1.32 %) |
May 04 2021 | AMGN | AMGEN INC | Santos Esteban | EVP, Operations | Payment of Exercise | F | 239.64 | 651 | 156,006 | 51,793 | 52.4 K to 51.8 K (-1.24 %) |
May 04 2021 | AMGN | AMGEN INC | Santos Esteban | EVP, Operations | Grant | A | 0.00 | 3,964 | 0 | 52,444 | 48.5 K to 52.4 K (+8.18 %) |
May 04 2021 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Option Exercise | A | 239.64 | 34,782 | 8,335,158 | 34,782 | |
May 04 2021 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Payment of Exercise | F | 239.64 | 745 | 178,532 | 44,472 | 45.2 K to 44.5 K (-1.65 %) |
May 04 2021 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Payment of Exercise | F | 239.64 | 1,109 | 265,761 | 45,217 | 46.3 K to 45.2 K (-2.39 %) |
May 04 2021 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Grant | A | 0.00 | 4,006 | 0 | 46,326 | 42.3 K to 46.3 K (+9.47 %) |
May 04 2021 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Option Exercise | A | 239.64 | 6,159 | 1,475,943 | 6,159 | |
May 04 2021 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Payment of Exercise | F | 239.64 | 220 | 52,721 | 44,787 | 45 K to 44.8 K (-0.49 %) |
May 04 2021 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Payment of Exercise | F | 239.64 | 139 | 33,310 | 45,007 | 45.1 K to 45 K (-0.31 %) |
May 04 2021 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Grant | A | 0.00 | 709 | 0 | 45,146 | 44.4 K to 45.1 K (+1.60 %) |
May 04 2021 | AMGN | AMGEN INC | Louie Linda H. | VP, Finance & CAO | Option Exercise | A | 239.64 | 2,608 | 624,981 | 2,608 | |
May 04 2021 | AMGN | AMGEN INC | Louie Linda H. | VP, Finance & CAO | Payment of Exercise | F | 239.64 | 17 | 4,074 | 8,266 | 8.3 K to 8.3 K (-0.21 %) |
May 04 2021 | AMGN | AMGEN INC | Louie Linda H. | VP, Finance & CAO | Payment of Exercise | F | 239.64 | 18 | 4,314 | 8,283 | 8.3 K to 8.3 K (-0.22 %) |
May 04 2021 | AMGN | AMGEN INC | Louie Linda H. | VP, Finance & CAO | Grant | A | 0.00 | 300 | 0 | 8,301 | 8 K to 8.3 K (+3.75 %) |
May 04 2021 | AMGN | AMGEN INC | Johnston Lori A | EVP, HR | Option Exercise | A | 239.64 | 28,623 | 6,859,216 | 28,623 | |
May 04 2021 | AMGN | AMGEN INC | Johnston Lori A | EVP, HR | Payment of Exercise | F | 239.64 | 335 | 80,279 | 37,365 | 37.7 K to 37.4 K (-0.89 %) |
May 04 2021 | AMGN | AMGEN INC | Johnston Lori A | EVP, HR | Payment of Exercise | F | 239.64 | 355 | 85,072 | 37,700 | 38.1 K to 37.7 K (-0.93 %) |
May 04 2021 | AMGN | AMGEN INC | Johnston Lori A | EVP, HR | Grant | A | 0.00 | 3,296 | 0 | 38,055 | 34.8 K to 38.1 K (+9.48 %) |
May 04 2021 | AMGN | AMGEN INC | Grygiel Nancy A. | SVP & CCO | Option Exercise | A | 239.64 | 5,072 | 1,215,454 | 5,072 | |
May 04 2021 | AMGN | AMGEN INC | Grygiel Nancy A. | SVP & CCO | Payment of Exercise | F | 239.64 | 55 | 13,180 | 12,461 | 12.5 K to 12.5 K (-0.44 %) |
May 04 2021 | AMGN | AMGEN INC | Grygiel Nancy A. | SVP & CCO | Payment of Exercise | F | 239.64 | 62 | 14,858 | 12,516 | 12.6 K to 12.5 K (-0.49 %) |
May 04 2021 | AMGN | AMGEN INC | Grygiel Nancy A. | SVP & CCO | Grant | A | 0.00 | 584 | 0 | 12,578 | 12 K to 12.6 K (+4.87 %) |
May 04 2021 | AMGN | AMGEN INC | Griffith Peter H. | EVP & CFO | Option Exercise | A | 239.64 | 28,985 | 6,945,965 | 28,985 | |
May 04 2021 | AMGN | AMGEN INC | Griffith Peter H. | EVP & CFO | Grant | A | 0.00 | 3,338 | 0 | 25,960 | 22.6 K to 26 K (+14.76 %) |
May 04 2021 | AMGN | AMGEN INC | Graham Jonathan P | EVP, Gen. Counsel & ... | Option Exercise | A | 239.64 | 32,971 | 7,901,170 | 32,971 | |
May 04 2021 | AMGN | AMGEN INC | Graham Jonathan P | EVP, Gen. Counsel & ... | Payment of Exercise | F | 239.64 | 548 | 131,323 | 46,633 | 47.2 K to 46.6 K (-1.16 %) |
May 04 2021 | AMGN | AMGEN INC | Graham Jonathan P | EVP, Gen. Counsel & ... | Payment of Exercise | F | 239.64 | 581 | 139,231 | 47,181 | 47.8 K to 47.2 K (-1.22 %) |
May 04 2021 | AMGN | AMGEN INC | Graham Jonathan P | EVP, Gen. Counsel & ... | Grant | A | 0.00 | 3,797 | 0 | 47,762 | 44 K to 47.8 K (+8.64 %) |
May 04 2021 | AMGN | AMGEN INC | Gordon Murdo | EVP Global Commerci ... | Option Exercise | A | 239.64 | 36,231 | 8,682,397 | 36,231 | |
May 04 2021 | AMGN | AMGEN INC | Gordon Murdo | EVP Global Commerci ... | Payment of Exercise | F | 239.64 | 782 | 187,398 | 44,848 | 45.6 K to 44.8 K (-1.71 %) |
May 04 2021 | AMGN | AMGEN INC | Gordon Murdo | EVP Global Commerci ... | Grant | A | 0.00 | 4,172 | 0 | 45,630 | 41.5 K to 45.6 K (+10.06 %) |
May 03 2021 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Option Exercise | A | 239.64 | 115,307 | 27,632,169 | 115,307 | |
May 03 2021 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Payment of Exercise | F | 239.64 | 2,850 | 682,974 | 594,173 | 597 K to 594.2 K (-0.48 %) |
May 03 2021 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Payment of Exercise | F | 239.64 | 2,902 | 695,435 | 597,023 | 599.9 K to 597 K (-0.48 %) |
May 03 2021 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Grant | A | 0.00 | 13,280 | 0 | 599,925 | 586.6 K to 599.9 K (+2.26 %) |
May 03 2021 | AMGN | AMGEN INC | Kullman Ellen Jamison | Director | Grant | A | 0.00 | 136 | 0 | 7,094 | 7 K to 7.1 K (+1.95 %) |
May 03 2021 | AMGN | AMGEN INC | HOLLEY CHARLES M | Director | Grant | A | 0.00 | 167 | 0 | 4,256 | 4.1 K to 4.3 K (+4.08 %) |
Apr 28 2021 | AMGN | AMGEN INC | Santos Esteban | EVP, Operations | Payment of Exercise | F | 255.52 | 564 | 144,113 | 48,480 | 49 K to 48.5 K (-1.15 %) |
Apr 28 2021 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Payment of Exercise | F | 255.52 | 174 | 44,460 | 42,320 | 42.5 K to 42.3 K (-0.41 %) |
Apr 28 2021 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Payment of Exercise | F | 255.52 | 128 | 32,707 | 44,437 | 44.6 K to 44.4 K (-0.29 %) |
Apr 28 2021 | AMGN | AMGEN INC | Louie Linda H. | VP, Finance & CAO | Payment of Exercise | F | 255.52 | 16 | 4,088 | 8,001 | 8 K to 8 K (-0.20 %) |
Apr 28 2021 | AMGN | AMGEN INC | Johnston Lori A | EVP, HR | Payment of Exercise | F | 255.52 | 345 | 88,154 | 34,759 | 35.1 K to 34.8 K (-0.98 %) |
Apr 28 2021 | AMGN | AMGEN INC | Grygiel Nancy A. | SVP & CCO | Payment of Exercise | F | 255.52 | 57 | 14,565 | 11,994 | 12.1 K to 12 K (-0.47 %) |
Apr 28 2021 | AMGN | AMGEN INC | Graham Jonathan P | EVP, Gen. Counsel & ... | Payment of Exercise | F | 255.52 | 564 | 144,113 | 43,965 | 44.5 K to 44 K (-1.27 %) |
Apr 28 2021 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Payment of Exercise | F | 255.52 | 2,617 | 668,696 | 586,645 | 589.3 K to 586.6 K (-0.44 %) |
Apr 15 2021 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Option Exercise | M | 71.64 | 1,000 | 71,640 | 1,000 | |
Apr 15 2021 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Sell | S | 249.98 | 1,000 | 249,980 | 15,927 | 16.9 K to 15.9 K (-5.91 %) |
Apr 15 2021 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Buy | M | 71.64 | 1,000 | 71,640 | 16,927 | 15.9 K to 16.9 K (+6.28 %) |
Mar 22 2021 | AMGN | AMGEN INC | Santos Esteban | EVP, Operations | Payment of Exercise | F | 244.42 | 4,360 | 1,065,671 | 49,044 | 53.4 K to 49 K (-8.16 %) |
Mar 22 2021 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Payment of Exercise | F | 244.42 | 1,401 | 342,432 | 42,494 | 43.9 K to 42.5 K (-3.19 %) |
Mar 22 2021 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Payment of Exercise | F | 244.42 | 991 | 242,220 | 44,565 | 45.6 K to 44.6 K (-2.18 %) |
Mar 22 2021 | AMGN | AMGEN INC | Louie Linda H. | VP, Finance & CAO | Payment of Exercise | F | 244.42 | 115 | 28,108 | 8,017 | 8.1 K to 8 K (-1.41 %) |
Mar 22 2021 | AMGN | AMGEN INC | Johnston Lori A | EVP, HR | Payment of Exercise | F | 244.42 | 2,803 | 685,109 | 35,104 | 37.9 K to 35.1 K (-7.39 %) |
Mar 22 2021 | AMGN | AMGEN INC | Grygiel Nancy A. | SVP & CCO | Payment of Exercise | F | 244.42 | 435 | 106,323 | 12,051 | 12.5 K to 12.1 K (-3.48 %) |
Mar 22 2021 | AMGN | AMGEN INC | Graham Jonathan P | EVP, Gen. Counsel & ... | Payment of Exercise | F | 244.42 | 4,360 | 1,065,671 | 44,529 | 48.9 K to 44.5 K (-8.92 %) |
Mar 22 2021 | AMGN | AMGEN INC | Gordon Murdo | EVP Global Commerci ... | Payment of Exercise | F | 244.42 | 8,989 | 2,197,091 | 41,458 | 50.4 K to 41.5 K (-17.82 %) |
Mar 22 2021 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Payment of Exercise | F | 244.42 | 21,190 | 5,179,260 | 589,262 | 610.5 K to 589.3 K (-3.47 %) |
Mar 10 2021 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Option Exercise | M | 71.64 | 1,000 | 71,640 | 2,000 | |
Mar 10 2021 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Sell | S | 231.53 | 1,000 | 231,530 | 15,805 | 16.8 K to 15.8 K (-5.95 %) |
Mar 10 2021 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Buy | M | 71.64 | 1,000 | 71,640 | 16,805 | 15.8 K to 16.8 K (+6.33 %) |
Mar 04 2021 | AMGN | AMGEN INC | Santos Esteban | EVP, Operations | Grant | A | 0.00 | 8,725 | 0 | 53,251 | 44.5 K to 53.3 K (+19.60 %) |
Mar 04 2021 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Grant | A | 0.00 | 2,803 | 0 | 43,715 | 40.9 K to 43.7 K (+6.85 %) |
Mar 04 2021 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Grant | A | 0.00 | 2,648 | 0 | 45,504 | 42.9 K to 45.5 K (+6.18 %) |
Mar 04 2021 | AMGN | AMGEN INC | Louie Linda H. | VP, Finance & CAO | Grant | A | 0.00 | 467 | 0 | 8,113 | 7.6 K to 8.1 K (+6.11 %) |
Mar 04 2021 | AMGN | AMGEN INC | Johnston Lori A | EVP, HR | Grant | A | 0.00 | 5,608 | 0 | 37,682 | 32.1 K to 37.7 K (+17.48 %) |
Mar 04 2021 | AMGN | AMGEN INC | Grygiel Nancy A. | SVP & CCO | Grant | A | 0.00 | 1,245 | 0 | 12,401 | 11.2 K to 12.4 K (+11.16 %) |
Mar 04 2021 | AMGN | AMGEN INC | Graham Jonathan P | EVP, Gen. Counsel & ... | Grant | A | 0.00 | 8,725 | 0 | 48,670 | 39.9 K to 48.7 K (+21.84 %) |
Mar 04 2021 | AMGN | AMGEN INC | Gordon Murdo | EVP Global Commerci ... | Grant | A | 0.00 | 17,989 | 0 | 50,159 | 32.2 K to 50.2 K (+55.92 %) |
Mar 04 2021 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Grant | A | 0.00 | 38,953 | 0 | 609,806 | 570.9 K to 609.8 K (+6.82 %) |
Feb 22 2021 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Option Exercise | M | 54.69 | 73,500 | 4,019,715 | 0 | |
Feb 22 2021 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Payment of Exercise | F | 235.61 | 47,527 | 11,197,836 | 570,853 | 618.4 K to 570.9 K (-7.69 %) |
Feb 22 2021 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Buy | M | 54.69 | 73,500 | 4,019,715 | 618,380 | 544.9 K to 618.4 K (+13.49 %) |
Feb 16 2021 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Option Exercise | M | 54.69 | 2,300 | 125,787 | 0 | |
Feb 16 2021 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Payment of Exercise | F | 237.21 | 1,147 | 272,080 | 40,912 | 42.1 K to 40.9 K (-2.73 %) |
Feb 16 2021 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Buy | M | 54.69 | 2,300 | 125,787 | 42,059 | 39.8 K to 42.1 K (+5.78 %) |
Feb 10 2021 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Option Exercise | M | 71.64 | 1,000 | 71,640 | 3,000 | |
Feb 10 2021 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Sell | S | 238.40 | 1,000 | 238,400 | 15,805 | 16.8 K to 15.8 K (-5.95 %) |
Feb 10 2021 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Buy | M | 71.64 | 1,000 | 71,640 | 16,805 | 15.8 K to 16.8 K (+6.33 %) |
Feb 09 2021 | AMGN | AMGEN INC | Johnston Lori A | EVP, HR | Payment of Exercise | F | 236.32 | 474 | 112,016 | 32,074 | 32.5 K to 32.1 K (-1.46 %) |
Feb 08 2021 | AMGN | AMGEN INC | Williams R Sanders | Director | Sell | S | 237.99 | 250 | 59,498 | 4,659 | 4.9 K to 4.7 K (-5.09 %) |
Feb 08 2021 | AMGN | AMGEN INC | Kullman Ellen Jamison | Director | Grant | A | 0.00 | 17 | 0 | 6,908 | 6.9 K to 6.9 K (+0.25 %) |
Feb 05 2021 | AMGN | AMGEN INC | Graham Jonathan P | EVP, Gen. Counsel & ... | Sell | S | 236.51 | 11,110 | 2,627,625 | 39,945 | 51.1 K to 39.9 K (-21.76 %) |
Jan 14 2021 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Option Exercise | M | 71.64 | 1,000 | 71,640 | 4,000 | |
Jan 14 2021 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Sell | S | 235.99 | 1,000 | 235,990 | 15,805 | 16.8 K to 15.8 K (-5.95 %) |
Jan 14 2021 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Buy | M | 71.64 | 1,000 | 71,640 | 16,805 | 15.8 K to 16.8 K (+6.33 %) |
Dec 18 2020 | AMGN | AMGEN INC | AMGEN INC | 10% Owner | Grant | A | 260.95 | 25,762 | 6,722,504 | 18,778,273 | 18.8 M to 18.8 M (+0.14 %) |
Dec 18 2020 | AMGN | AMGEN INC | AMGEN INC | 10% Owner | Grant | A | 260.95 | 25,762 | 6,722,504 | 18,778,273 | 18.8 M to 18.8 M (+0.14 %) |
Dec 17 2020 | AMGN | AMGEN INC | AMGEN INC | 10% Owner | Grant | A | 260.54 | 74,624 | 19,442,507 | 18,752,511 | 18.7 M to 18.8 M (+0.40 %) |
Dec 17 2020 | AMGN | AMGEN INC | AMGEN INC | 10% Owner | Grant | A | 248.26 | 85,573 | 21,244,456 | 18,677,887 | 18.6 M to 18.7 M (+0.46 %) |
Dec 17 2020 | AMGN | AMGEN INC | AMGEN INC | 10% Owner | Grant | A | 239.31 | 67,941 | 16,258,723 | 18,592,314 | 18.5 M to 18.6 M (+0.37 %) |
Nov 04 2020 | AMGN | AMGEN INC | Kullman Ellen Jamison | Director | Grant | A | 0.00 | 141 | 0 | 6,846 | 6.7 K to 6.8 K (+2.10 %) |
Aug 25 2020 | AMGN | AMGEN INC | AMGEN INC | 10% Owner | Grant | A | 248.49 | 59,390 | 14,757,578 | 18,524,373 | 18.5 M to 18.5 M (+0.32 %) |
Aug 24 2020 | AMGN | AMGEN INC | AMGEN INC | 10% Owner | Grant | A | 239.10 | 59,390 | 14,199,906 | 18,464,983 | 18.4 M to 18.5 M (+0.32 %) |
Aug 24 2020 | AMGN | AMGEN INC | AMGEN INC | 10% Owner | Grant | A | 230.18 | 64,176 | 14,772,012 | 18,405,593 | 18.3 M to 18.4 M (+0.35 %) |
Aug 20 2020 | AMGN | AMGEN INC | AMGEN INC | 10% Owner | Grant | A | 234.99 | 64,176 | 15,080,981 | 18,341,417 | 18.3 M to 18.3 M (+0.35 %) |
Aug 20 2020 | AMGN | AMGEN INC | AMGEN INC | 10% Owner | Grant | A | 234.88 | 64,176 | 15,073,454 | 18,277,241 | 18.2 M to 18.3 M (+0.35 %) |
Aug 20 2020 | AMGN | AMGEN INC | AMGEN INC | 10% Owner | Grant | A | 230.18 | 40,000 | 9,207,188 | 18,213,065 | 18.2 M to 18.2 M (+0.22 %) |
Aug 19 2020 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Option Exercise | M | 54.69 | 1,000 | 54,690 | 5,000 | |
Aug 19 2020 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Sell | S | 241.02 | 1,000 | 241,020 | 15,589 | 16.6 K to 15.6 K (-6.03 %) |
Aug 19 2020 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Buy | M | 54.69 | 1,000 | 54,690 | 16,589 | 15.6 K to 16.6 K (+6.41 %) |
Aug 10 2020 | AMGN | AMGEN INC | Williams R Sanders | Director | Sell | S | 242.95 | 250 | 60,738 | 5,159 | 5.4 K to 5.2 K (-4.62 %) |
Aug 03 2020 | AMGN | AMGEN INC | Santos Esteban | EVP, Operations | Payment of Exercise | F | 244.67 | 2,165 | 529,711 | 44,376 | 46.5 K to 44.4 K (-4.65 %) |
Aug 03 2020 | AMGN | AMGEN INC | Grygiel Nancy A. | SVP & CCO | Payment of Exercise | F | 244.67 | 290 | 70,954 | 11,026 | 11.3 K to 11 K (-2.56 %) |
Aug 03 2020 | AMGN | AMGEN INC | Grygiel Nancy A. | SVP & CCO | Grant | A | 0.00 | 8,174 | 0 | 11,316 | 3.1 K to 11.3 K (+260.15 %) |
Aug 03 2020 | AMGN | AMGEN INC | MILES AMY E | Director | Grant | A | 0.00 | 408 | 0 | 408 | 0 to 408 |
Aug 03 2020 | AMGN | AMGEN INC | Kullman Ellen Jamison | Director | Grant | A | 0.00 | 241 | 0 | 6,663 | 6.4 K to 6.7 K (+3.75 %) |
Jul 22 2020 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Option Exercise | M | 54.69 | 1,000 | 54,690 | 6,000 | |
Jul 22 2020 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Sell | S | 259.79 | 1,000 | 259,790 | 15,589 | 16.6 K to 15.6 K (-6.03 %) |
Jul 22 2020 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Buy | M | 54.69 | 1,000 | 54,690 | 16,589 | 15.6 K to 16.6 K (+6.41 %) |
Jul 16 2020 | AMGN | AMGEN INC | AMGEN INC | 10% Owner | Grant | A | 14.23 | 29,614,832 | 421,442,751 | 236,249,845 | 206.6 M to 236.2 M (+14.33 %) |
Jun 17 2020 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Option Exercise | M | 54.69 | 1,000 | 54,690 | 7,000 | |
Jun 17 2020 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Sell | S | 228.54 | 1,000 | 228,540 | 15,576 | 16.6 K to 15.6 K (-6.03 %) |
Jun 17 2020 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Buy | M | 54.69 | 1,000 | 54,690 | 16,576 | 15.6 K to 16.6 K (+6.42 %) |
May 20 2020 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Option Exercise | M | 54.69 | 1,000 | 54,690 | 8,000 | |
May 20 2020 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Sell | S | 229.27 | 1,000 | 229,270 | 15,482 | 16.5 K to 15.5 K (-6.07 %) |
May 20 2020 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Buy | M | 54.69 | 1,000 | 54,690 | 16,482 | 15.5 K to 16.5 K (+6.46 %) |
May 07 2020 | AMGN | AMGEN INC | Hassan Fred | Director | Grant | A | 0.00 | 846 | 0 | 9,191 | 8.3 K to 9.2 K (+10.14 %) |
May 07 2020 | AMGN | AMGEN INC | Garland Greg C. | Director | Grant | A | 0.00 | 846 | 0 | 9,024 | 8.2 K to 9 K (+10.34 %) |
May 07 2020 | AMGN | AMGEN INC | ECKERT ROBERT | Director | Grant | A | 0.00 | 846 | 0 | 12,031 | 11.2 K to 12 K (+7.56 %) |
May 07 2020 | AMGN | AMGEN INC | Druker Brian | Director | Grant | A | 0.00 | 846 | 0 | 2,719 | 1.9 K to 2.7 K (+45.17 %) |
May 07 2020 | AMGN | AMGEN INC | Austin Wanda M | Director | Grant | A | 0.00 | 846 | 0 | 3,194 | 2.3 K to 3.2 K (+36.03 %) |
May 07 2020 | AMGN | AMGEN INC | Santos Esteban | EVP, Operations | Option Exercise | A | 236.36 | 28,341 | 6,698,679 | 28,341 | |
May 07 2020 | AMGN | AMGEN INC | Santos Esteban | EVP, Operations | Grant | A | 0.00 | 3,384 | 0 | 46,433 | 43 K to 46.4 K (+7.86 %) |
May 07 2020 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Option Exercise | A | 236.36 | 29,050 | 6,866,258 | 29,050 | |
May 07 2020 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Grant | A | 0.00 | 3,469 | 0 | 41,408 | 37.9 K to 41.4 K (+9.14 %) |
May 07 2020 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Option Exercise | A | 236.36 | 10,628 | 2,512,034 | 10,628 | |
May 07 2020 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Grant | A | 0.00 | 1,269 | 0 | 42,773 | 41.5 K to 42.8 K (+3.06 %) |
May 07 2020 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Option Exercise | A | 236.36 | 5,668 | 1,339,688 | 5,668 | |
May 07 2020 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Grant | A | 0.00 | 676 | 0 | 24,751 | 24.1 K to 24.8 K (+2.81 %) |
May 07 2020 | AMGN | AMGEN INC | Santos Esteban | EVP, Operations | Option Exercise | A | 236.36 | 28,341 | 6,698,679 | 28,341 | |
May 07 2020 | AMGN | AMGEN INC | Santos Esteban | EVP, Operations | Grant | A | 0.00 | 3,384 | 0 | 46,433 | 43 K to 46.4 K (+7.86 %) |
May 07 2020 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Option Exercise | A | 236.36 | 29,050 | 6,866,258 | 29,050 | |
May 07 2020 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Grant | A | 0.00 | 3,469 | 0 | 41,408 | 37.9 K to 41.4 K (+9.14 %) |
May 07 2020 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Option Exercise | A | 236.36 | 10,628 | 2,512,034 | 10,628 | |
May 07 2020 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Grant | A | 0.00 | 1,269 | 0 | 42,773 | 41.5 K to 42.8 K (+3.06 %) |
May 07 2020 | AMGN | AMGEN INC | Johnston Lori A | EVP, HR | Option Exercise | A | 236.36 | 24,799 | 5,861,492 | 24,799 | |
May 07 2020 | AMGN | AMGEN INC | Johnston Lori A | EVP, HR | Grant | A | 0.00 | 2,961 | 0 | 32,268 | 29.3 K to 32.3 K (+10.10 %) |